NutraGenesis is pleased to announce that Health Canada has issued an NPN for the company’s flagship ingredient Sensoril® (NPN 80047814). This new product license issuance allows Sensoril to be sold throughout Canada.
“We are very pleased that our Sensoril ingredient is available for Canadian dietary supplement marketers to formulate with,” said Suzanne McNeary, cofounder and president of NutraGenesis. “We believe that the compelling claims that were afforded in the product license will be very attractive to the Canadian marketplace.” NutraGenesis engaged its long-term Canadian consulting firm, NHP Consulting Inc. to work on the NPN for Sensoril.
“It was a pleasure to have been a part of the licensing of this fantastic ingredient, Sensoril. NutraGenesis’ commitment to research and development as well as the safety and efficacy of their ingredients is evidenced by their new NPN,” stated Adrian Rodriguez, M.Sc., project manager for NHP Consulting. “Sensoril obtained unique and novel health claims from the Natural Health Products Directorate branch of Health Canada, attesting to one of the highest and strictest clinical and regulatory standards of evidence for safety and efficacy around the world. It is with pride that we endorse Sensoril,” he added.
The claims include “Helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate,” “Helps reduce cortisol and C-reactive protein levels, the biomarkers of physical stress” and “Helps support cardiovascular health.”
Multi-patented Sensoril is supported by seven human clinical trials and is manufactured by NutraGenesis partner Natreon Inc. of New Brunswick, N.J.